Grant Larsen is the Chief Commercial Officer for Aequus Pharma, (TSX-V) a publicly traded, specialty pharmaceutical company with a primary focus in Ophthalmology, Dry Eye, Glaucoma, and Diagnostic Devices.
Grant has more than 20 years’ experience as a CEO, board advisor, corporate executive, and entrepreneur. During his career, Grant has developed, modelled, and launched hundreds of products in categories ranging from pharmaceuticals, consumer packaged goods, OTC, medical devices, PC games, and marketing technology. His diverse skillset includes extensive advisory roles, strategic consulting, organizational restructuring, keynote speaking, training and healthcare technology integration.
Mr. Larsen’s academic background includes an MBA, Honours Business Degree, and a University Business Professor for 5-years in Canada.
Day 1: Oct 15, 2025
Day 2: Oct 15, 2025
2:30 pm
CASE STUDY: NAVIGATING THE ULTRA-NICHE
Targeted Marketing Strategies for Rare Disease Therapies
Rare disease therapies, like any niche area, require a specialized and personalized marketing approach. Source best practices on:
- Identifying and engaging small, dispersed patient populations.
- Building trust with patient advocacy groups and HCP key opinion leaders.
- Overcoming awareness and diagnostic challenges in rare diseases.
Develop your strategies for ultra rare drug marketing.
